Expression of sex hormone-binding globulin mrima in uterine cervical cancers

Tumor Biology

Volumn 18, Issue 1, 1997, Pages 6-12

  Misao, Ryou ^a   Nakanishi, Yoshihito ^a   Fujimoto, Jiro ^a   Hori, Masashi ^a   Ichigo, Satoshi ^a   Tamaya, Teruhiko ^a  

^a GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

mRNA; Sex hormone binding globulin; Uterine cervical cancers

Indexed keywords

MESSENGER RNA; SEX HORMONE BINDING GLOBULIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; UTERINE CERVIX CANCER;

EID: 0031012653     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1159/000218010     Document Type: Article

References (29)

1. Pommcrcnke WT: Cyclic changes in the physical and chemical properties of cervical mucus, Am J Obstct Gynecol 1946:52:1023-1031.
2. MacDonald RR: Cyclic changes in cervical mucus, J Obstet Gynecol Br Commonw 1969;76:1090-1099.
3. Terenius L, Lindcll A, Pcrsson H: Binding of estradiol-17p to human cancer tissue of the female genital tract, Cancer Res 1971:31:1895— 1898.
4. Sanborn BM, Held B, Kuo HS: Hormonal action in human cervix, II, Specific progestogen binding in human cervix, J Steroid Biochem 1976:7:665-672.
5. Soutter WP, Pergoraro EI, Green-Thompson RW, Naidoo DV, Jou-bert SM, Philpott RH: Nuclear and cytoplasmic oestrogen receptors in squamous carcinoma of the cervix, BrJ Cancer 1981;44:154-159.
6. Gao YL, Twiggs LB, Leungs BS, Yu WCY, Potish RA, Okagaki T, Adcock LL, Prcm KA: Cytoplasmic estrogen and progesterone receptors in primary cervical carcinoma: Clinical and histopathologic correlates, Am J Obstet Gynecol 1983:146: 299-306.
7. Fujimoto J, Tamava T, Watanabc Y, Arahori K, Sato S, Okada H: Steroid receptors and histological types in cervical cancer, Asia-Oceania J Obstet Gynecol 1986:12:541-548.
8. Hunter RH, Longcope C, Keough P: Steroid hormone receptors in carcinoma of the cervix, Cancer 1987:60: 392-396.
9. Strel'chyonok OA, Avvakumov GV, Survilo LI: A recognition system for sex hormone binding protcin-cstra-diol complex in human decidual endometrium plasma membranes, Biochim Biophys Acta 1984;802: 459-466.
10. Hryb DJ, Khan MS, Roser W: Tes-tosterone-estradiol-binding globulin binds to human prostatic cell membranes, Biochem Biophys Res Commun 1985:128:432-440.
11. Mcrcicr-Bodard C, Radanyi C, Roux C, Groyer MT, Robel P, Dad-oune JP, Petra PH, Jolly DJ, Bau-licu EH: Cellular distribution and hormonal regulation of h-SBP, J Steroid Biochem 1987:27:297-307.
12. Sinnecker G, Hiort O, Kwan PWL, de Lellis RA: Immunohistochcmical localization of sex hormone binding globulin in normal and neoplastic breast tissue, Horm Metab Res 1990;22:47-50.
13. Misao R, Itoh N, Mori H, Fujimoto J, Tamaya T: Sex hormone-binding globulin tnRNA levels in human uterine endometrium, Eur J Endocrinol 1994:131:623-629.
14. Misao R, Hori M, Ichigo S, Fujimoto J, Tamaya T: Levels of sex hormone-binding globulin (SHBG) and corticosteroid-binding globulin (CBG) messenger ribonucleic acid (mRNA) in ovarian endometriosis, Reprod Nutr Dev 1995:35:155-165.
15. Mercier-Bodard C, Nivet V, Baulieu EE: Effects of hormones on SBP mRNA levels in human cancer cells, J Steroid Biochem 1991:40:777-785.
16. Plymate SR, Loop SM, Hoop RC, Wircn KM, Ostenson R, Hryb DJ, Rosner W: Effects of sex hormone binding globulin (SHBG) on human prostatic carcinoma, J Steroid Biochem 1991;40:833-839.
17. Misao R, Nakanishi Y, Ichigo S, Hori M, Fujimoto J, Tamaya T: Expression of sex hormone-binding globulin mRNA in human endometrial cancers, J Steroid Biochem Mo-lccBiol 1995;52:517-522.
18. Misao R, Nakanishi Y, Fujimoto J, Hori M, Ichigo S, Tamaya T: Expression of sex hormone-binding globulin mRNA in human ovarian cancers, Eur J Endocrinol 1995; 133: 327-334.
19. Poulscn HE, Taylor CW: Histological typing of female genital tract tumours, International Histological Classification of Tumours 13, Geneva, World Health Organization, 1975.
20. Announcement, Changes in definitions of clinical staging for carcinoma of the cervix and ovary: FIGO, Am J Obstet Gynecol 1987; 156: 263-264.
21. Hammond GL, Underhill DA, Smith CL, Goping IS, Harley MJ, Musto NA, Cheng CY, Bardin CW: The cDNA-dcduccd primary structure of human sex hormone-binding globulin and location of its steroid-binding domain, J Biol Chcm 1987; 215:100-104.
22. Vanden Heuvel JP, Tyson FL, Bell DA: Construction of recombinant RNA templates for use as internal standards in quantitative RT-PCR, Biotechniques 1993;14:395-398.
23. Chomczynski P, Sacch N: Single-step method of RNA isolation by acid guanidium thiocyanatc-phcnol-chloroform extraction, Anal Biochem 1987;162:156-159.
24. White JO, Jones RN, Croxtall JD, Glccson RP, Krausz T, Pervez S, Jamil A, Guida L, Beesley JE, Sout-ter WP: The human squamous cervical carcinoma cell line, HOG-1, is responsive to steroid hormones, Int J Cancer 1992;52:247-251.
25. Schneider A, Hotz M, Gissmann L: Increased prevalence of human papillomaviruses in the lower genital tract of pregnant women, Int J Cancer 1987;40:198-201.
26. Aubom KJ, Woodworth C, DiPaolo JA, Bradlow HL: The interaction between HPV infection and estrogen metabolism in cervical carcinogenesis, Int J Cancer 1991;49:867-869.
27. Mcrcier-Bodard C, Alfsen A, Bau-lieu EE: Sex steroid binding plasma protein, Acta Endocrinol (Copenh) Suppl 1970;147:204-224.
28. Strcl’chycnok OA, Avvakumov GV: Specific steroid-binding glycoproteins of human blood plasma: Novel data on their structure and function, J Steroid Biochem 1990:35:519-534.
29. Bonte J, De Coster JM, Idc P, Billiet G: Hormone prophylaxis and hormone therapy in the treatment of endometrial adenocarcinoma by means of medroxyprogesterone acetate; in Brush MG, King RJB, Taylor RW (eds): Endometrial Cancer, Bailliere Tindall, London, 1978, pp 192-205.